Steven I Park (Steven Park)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Newly Diagnosed

Hodgkin Lymphoma

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin, Kyle Wagner, Seungpyo Hong, Andrew Z Wang, Steven I Park
Correction to "Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma". ACS nano 18 (23) (2024)
Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin, Kyle Wagner, Seungpyo Hong, Andrew Z Wang, Steven I Park
Correction to "Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma". ACS nano (2024)
Issam S Hamadeh, Jai Narendra Patel, Ryan Jacobs, Hang Zeng, Jiaxian He, Bei Hu, Tamara Kay Moyo, Amy Soni, Steven I Park, Ed Copelan, Belinda Avalos, Alicia Hamilton, Nury Steuerwald, Nilanjan Ghosh
Genetic Predictors of Ibrutinib-Related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Timothy J Voorhees, Beibo Zhao, Jorge Oldan, George E Hucks, Amir Khandani, Christopher Dittus, Jennifer Smith, J Kaitlin Morrison, Catherine Cheng, Anastasia Ivanova, Steven I Park, Thomas Shea, Anne W Beaven, Gianpietro Dotti, Jonathan S Serody, Barbara Savoldo, Natalie Sophia Grover
Pretherapy metabolic tumor volume associates with response to CD30 CAR T cells in Hodgkin lymphoma. Blood advances (2021)
Steven I Park, Carolina P Lin, Natalie Ren, Steven P Angus, Dirk P Dittmer, Michael Foote, Trevor Parton, Aadra P Bhatt, Yuri D Fedoriw, Daniel P Roth, Marissa L Cann, Gary L Johnson, Blossom Damania
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma. Targeted oncology 14 (5) (2020)
Kin Man Au, Andrew Z Wang, Steven I Park
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma. Science advances 6 (14) (2020)
Kin Man Au, Steven I Park, Andrew Z Wang
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy. Science advances 6 (27) (2020)